Long-term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short-term tacrolimus immunosuppression

Transplant International

Volumn 14, Issue 5, 2001, Pages 311-319

  Fukada, Johji ^a   Kurimoto, Yoshihiko ^a   Ruiz, Phillip ^a   Aitouche, Abdelouahab ^a   Zeevi, Adriana ^b   Li, S ^a   Kubota, Toru ^c   Pham, S M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Allografts vasculopathy; Bone marrow cells; Intrathymic injection; Portal venous injection; Rat cardiac allograft

Indexed keywords

ANTIGEN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; THYMUS; VASCULAR DISEASE;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, INBRED ACI; RATS, INBRED WF; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034758660     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470100341     Document Type: Article

References (37)

1. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents
2. Hepatic suppression of sensitization to antigen absorbed into the portal system
3. Mixed allogenic chimerism in the rat
4. Analysis of chronic rejection and obliterative arteriopathy
5. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigenspecific tolerance for delayed-type hypersensitibity by portal venous inoculation with allogenic cells
6. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoitetic chimerism and tolerance for cardiac allografts
7. Mixed allogenic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model
8. Chimerism and thoracic organ transplantation
9. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage
10. Spontaneous long-term acceptance of RT-1-incompatible liver allografts in inbred rats: Analysis of the immune status
11. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival
12. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: Immunologically specific entrapment of allogeneic cells within the liver
13. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: What is "hepatic tolerance"?
14. Simultaneous transplantation and intrathymic tolerance induction. A method with clinical potential
15. Organ-specific unresponsiveness induced by intrathymic injection of donor bone marrow cells and a short course of immunosuppression in the rat heart transplantation model
16. An immunological suppressor cell inactivating cytotoxic T lymphocyte precusors recognizing it
17. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to BM1 cardiac grafts
18. A strategy for organ allografts without using immunosuppressants or irradiation
19. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against self antigens
20. Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow
21. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B irradiated donor spleen cells
22. Improved technique of heart transplantation in rats
23. Immunosuppressive therapy abrogates unresponsiveness to renal allograft induced by thymic recognition of donor antigens
24. A prospective trial of tacrolimus (FK506) in clinical heart transplantation: Intermediate-term results
25. Induction of donor-specific unresponsiveness by intrathymic islet transplantation
26. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells
27. Murine liver allograft transplantation: Tolerance and donor cell chimerism
28. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
29. Mechanisms of acquired thymic unresponsiveness to renal allografts
30. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens
31. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism
32. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow
33. Straindependent difference in prolongation of rat cardiac allograft survival after intrathymic injection of donor bone marrow and ALS treatment
34. The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice
35. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat
36. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance
37. Fate of alloeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection